Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis
- PMID: 39378095
- PMCID: PMC11494310
- DOI: 10.1073/pnas.2323052121
Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis
Abstract
Cardiac myosin-specific (MyHC) T cells drive the disease pathogenesis of immune checkpoint inhibitor-associated myocarditis (ICI-myocarditis). To determine whether MyHC T cells are tissue-resident memory T (TRM) cells, we characterized cardiac TRM cells in naive mice and established that they have a distinct phenotypic and transcriptional profile that can be defined by their upregulation of CD69, PD-1, and CXCR6. We then investigated the effects of cardiac injury through a modified experimental autoimmune myocarditis mouse model and an ischemia-reperfusion injury mouse model and determined that cardiac inflammation induces the recruitment of autoreactive MyHC TRM cells, which coexpress PD-1 and CD69. To investigate whether the recruited MyHC TRM cells could increase susceptibility to ICI-myocarditis, we developed a two-hit ICI-myocarditis mouse model where cardiac injury was induced, mice were allowed to recover, and then were treated with anti-PD-1 antibodies. We determined that mice who recover from cardiac injury are more susceptible to ICI-myocarditis development. We found that murine and human TRM cells share a similar location in the heart and aggregate along the perimyocardium. We phenotyped cells obtained from pericardial fluid from patients diagnosed with dilated cardiomyopathy and ischemic cardiomyopathy and established that pericardial T cells are predominantly CD69+ TRM cells that up-regulate PD-1. Finally, we determined that human pericardial macrophages produce IL-15, which supports and maintains pericardial TRM cells.
Keywords: ICI-myocarditis; PD-1; cardiac immunology; tissue-resident memory T cells.
Conflict of interest statement
Competing interests statement:Dr. Čiháková has research grants with CSL Behring and Cantargia. Neither grant conflicts with this project.
Figures
References
-
- Chambers C. A., Sullivan T. J., Allison J. P., Lymphoproliferation in CTLA-4–deficient mice is mediated by costimulation-dependent activation of CD4+ T cells Immunity 7, 885–895 (1997). - PubMed
-
- Ueda H., et al. , Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506–511 (2003). - PubMed
-
- Nishimura H., Minato N., Nakano T., Honjo T., Immunological studies on PD-1 deficient mice: Implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10, 1563–1572 (1998). - PubMed
-
- Martins F., et al. , Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance. Nat. Rev. Clin. Oncol. 16, 563–580 (2019). - PubMed
MeSH terms
Substances
Grants and funding
- NA/Katherine E. Welsh Fellowship
- R01HL118183/HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R01 HL136586/HL/NHLBI NIH HHS/United States
- R01 HL118183/HL/NHLBI NIH HHS/United States
- F31AR077406/HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- LX22NPO5104/National Institute for Research of Metabolic and Cardiovascular Diseases
- 19TPA34910007/American Heart Association (AHA)
- NA/Global Autoimmune Institute (GAI)
- NA/Delta Omega Scholarship
- T32 AI007417/AI/NIAID NIH HHS/United States
- 20TPA35490421/American Heart Association (AHA)
- F31 AR077406/AR/NIAMS NIH HHS/United States
- 5T32AI007417-25/HHS | NIH (NIH)
- NA/Matthew Poyner MVP Memorial Myocarditis Research Fund
- R01HL136586/HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- 2T32AI007417-26/HHS | NIH (NIH)
- NA/2018 Rhett Lundy Memorial Research Fellowship from the Myocarditis Foundation
- 23EIA1040103/American Heart Association (AHA)
LinkOut - more resources
Full Text Sources
